Log In
Print this Print this

biosimilar insulin glargine (SB9)

  Manage Alerts
Collapse Summary General Information
Company Samsung Group
DescriptionInsulin biosimilar
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today